Exchange: NASDAQ·Updated 07:30 PM EDT
PCVX logo

PCVX Vaxcyte Inc

$61.09
$0.78
(1.26%)
Today
Closed $61.09
$0.00
(0.00%)
After Hours
Reported EarningsAug 5
Mkt Cap$9.21B
Vol1.22M

About PCVX

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
58

Bullish Sentiment

How do you feel about PCVX?

Advertisement|Remove ads.